Ute Botzenhart | Medicine and Health Sciences | Research Excellence Award

Published on by Research Awards

Dr. Ute Botzenhart | Orthodontics | Research Excellence Award 

Dresden University of Technology | Germany

Dr. Ute Ulrike Botzenhart is a highly accomplished orthodontist and researcher with extensive expertise in dental medicine, craniofacial biology, and functional orthodontics. Affiliated with TU Dresden and actively engaged in international collaboration with the University of Poznan, her research focuses on the interplay between muscle function and the stomatognathic system, with particular emphasis on innovative therapeutic interventions such as botulinum toxin applications. Her doctoral and habilitation work reflects a strong foundation in both experimental and clinical research, including studies on laser applications in dentistry and functional modulation of oral structures. Dr. Botzenhart integrates advanced digital orthodontic technologies with evidence-based clinical practice, contributing to improved diagnostic and treatment outcomes. She is actively involved in teaching, project management, and interdisciplinary research, while maintaining clinical excellence in orthodontic care. Her memberships in leading professional societies and certifications in areas such as dental sleep medicine, sports dentistry, and digital volume tomography further highlight her commitment to continuous professional development and innovation in modern orthodontics.

Citation Metrics (Google Scholar)

  600
  500
  400
  300
  200
    50
     30
     10
       0

Citations
563

Documents
47

h-index
15

Citations

h-index

i10-index

View Google Scholar Profile
     View Scopus Profile

Featured Publications

Junning Ma | Medicine and Health Sciences | Young Scientist Award

Published on by Research Awards

Dr. Junning Ma | Medicine and Health Sciences | Young Scientist Award

Zhejiang University and Qing Hai University | China

Ma Juning is a clinician-scientist specializing in neurosurgery with a strong focus on nanomedicine and targeted therapies for neurological disorders. His research centers on engineering biomimetic nanoparticles and cell membrane-coated nanocarriers to improve drug delivery across complex biological barriers, particularly in glioma, stroke, and pituitary adenomas. He has led competitive projects funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation, highlighting his capacity for independent and innovative research. His international training, including a joint doctoral program at Yale University, has strengthened his expertise in translational neuroscience and advanced therapeutic strategies. Dr. Ma has contributed to high-impact publications in leading journals such as Biomaterials, Nano Letters, and Materials Today Bio, reflecting the significance of his work in tumor microenvironment targeting and immunotherapy. His interdisciplinary background integrates neurosurgery, nanotechnology, and stem cell research, aiming to develop clinically viable solutions for challenging brain diseases. In addition to research, he demonstrates leadership through active roles in academic and clinical communities. With a solid foundation in both basic science and clinical practice, he continues to advance precision medicine approaches for neurological disease treatment.

Citation Metrics (Scopus)

  500
  400
  300
  200
    50
     30
     10
       0

Citations
422

Documents
8

h-index
8

Citations

h-index

i10-index

View Scopus Profile
     View orcid Profile

Featured Publications

Ylenia Della Rocca | Medicine and Health Sciences | Research Excellence Award

Published on by Research Awards

Prof. Ylenia Della Rocca | Medicine and Health Sciences | Research Excellence Award 

Link University | Italy

Ylenia Della Rocca is an Associate Professor of Histology and Embryology and Physiology whose research profile is internationally recognized in the fields of stem cell biology, regenerative medicine, and advanced in vitro modeling for precision medicine. Her scientific activity is strongly interdisciplinary, integrating histology, embryology, molecular biology, biomaterials, and translational medicine, with a particular focus on induced pluripotent stem cells (iPSCs), extracellular vesicles, and 3D culture systems. Her core research line centers on the reprogramming of autologous human gingival mesenchymal stem cells into iPSCs and their differentiation toward functional cell types, especially cardiomyocytes and neural lineages. This work has led to innovative strategies for cardiac regeneration and personalized regenerative therapies, culminating in a patented non-integrative reprogramming and cardiomyogenic differentiation process. Through advanced molecular and morphological analyses, her studies elucidate the signaling pathways governing cell fate, inflammation, hypoxia response, and extracellular matrix remodeling. A distinctive element of her research is the development and application of organ-on-a-chip and tissue-on-a-chip platforms, including bone-on-a-chip and cardiac models, to study disease mechanisms, environmental pollutant toxicity, and therapeutic responses. Within national and international projects, she has contributed to the creation of physiologically relevant in vitro systems that reduce reliance on animal models while increasing translational relevance. Her work on environmental pollutants, such as bisphenol A and pesticides, has clarified their impact on inflammatory, apoptotic, and epigenetic pathways in stem cells and endothelial models.

View Orcid Profile

Featured Publications

Hou-Qun Ying | Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Research Awards

Prof. Hou-Qun Ying | Toxicology and Pharmaceutical Science | Research Excellence Award 

The Second Affiliated Hospital of Nanchang University | China

Dr. Hou-Qun Ying, PhD, born on July 18, 1985, in Shangrao, Jiangxi Province, China, is an accomplished clinical scientist specializing in cancer biomarkers, inflammation-related indices, molecular epidemiology, and therapeutic response prediction. He currently serves as the Vice Director of the Department of Clinical Laboratory Medicine at The Second Affiliated Hospital of Nanchang University, where he plays a leading role in translational research, diagnostic innovation, and clinical laboratory management. Dr. Ying earned his Ph.D. in Clinical Laboratory Diagnosis from Southeast University (2013–2016), after completing his Master of Medicine in Pathogenic Biology at Dali University and his Bachelor of Medicine in Medical Laboratory Science from Tianjin Medical University. His academic and professional journey reflects strong expertise in cancer diagnostics, genetic polymorphisms, biomarker development, and precision medicine. Dr. Ying has successfully led multiple competitive research grants, including the National Natural Science Foundation of China Youth Fund (2018–2020), exploring Hippo-pathway-related genetic variations and EGFR-TKI resistance in non-small cell lung cancer, and the 2024–2027 Regional Fund focusing on SP1 transcription factor–related genetic variations as biomarkers for bevacizumab resistance in metastatic colorectal cancer. His research contributions span more than 70 peer-reviewed publications, with many as first, co-first, or corresponding author in high-impact journals such as Scientific Reports, Oncotarget, Cancer Medicine, Therapeutic Advances in Medical Oncology, Frontiers in Oncology, Pharmacological Research, Biomarkers, Future Oncology, and J Inflammation Research. His studies have provided pivotal insights into inflammatory markers such as fibrinogen-to-pre-albumin ratio, albumin-to-fibrinogen ratio, dNLR, PLR, and novel composite biomarkers for cancer prognosis, treatment response prediction, early diagnosis, and recurrence risk stratification. He has also made influential contributions to colorectal cancer, gastric cancer, gallbladder carcinoma, hepatocellular carcinoma, and NSCLC through biomarker innovation, clinical prediction models, and meta-analytic evaluations. As a corresponding author, Dr. Ying has developed and validated numerous inflammation-based and genetic biomarker signatures, such as FPR, ADS score, MLPAS, CCMLP, and chronic inflammation indices, improving precision therapeutic decisions for chemotherapy, bevacizumab, 5-FU–based regimens, and TKIs. Additionally, his collaborative work extends to machine learning applications in early gastric cancer prediction, molecular mechanisms underlying cancer progression, and multi-omics approaches. With a distinguished record of scientific leadership, grant success, and impactful publications, Dr. Ying continues to advance clinical oncology diagnostics and personalized treatment strategies through rigorous research, innovation, and interdisciplinary collaboration.

Profiles: Scopus | Orcid

Featured Publications

Peng, Y., Shang, R., Wang, Z.-J., Ye, Q.-Y., Tang, X.-Y., Cheng, X.-X., & Ying, H.-Q. (2025). Chronic inflammatory comprehensive signature predicts oxaliplatin and 5-fluorouracil benefit in early colorectal cancer. Drug Design, Development and Therapy. https://doi.org/10.2147/DDDT.S556619

Lu, Y., Ye, Q.-Y., Mei, O., Li, Y.-N., Peng, Y., Ying, H.-Q., & Cheng, X.-X. (2025). Chronic inflammation index-based tumor subsite classification correlated with chemotherapy benefit and survival outcomes in stage II–III colorectal cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S517378

Ye, Q.-Y., Wang, Y.-Y., Wang, Z.-J., Lu, M., Peng, H.-X., Wang, X., Cheng, X.-X., & Ying, H.-Q. (2025). Robust predictive performance of MLPAS and CCMLP for clinical outcome and risk stratification in patients with colorectal cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S498028

Tian, H., Liu, Z., Zhang, Z., Zhang, L., Zong, Z., Liu, J., Ying, H., & Li, H. (2023). Clinical significance of fibrinogen and platelet to pre-albumin ratio in predicting the prognosis of advanced gastric cancer. Journal of Inflammation Research. https://doi.org/10.2147/JIR.S412033

Ying, H.-Q., Liao, Y.-C., Luo, Y.-R., Xiong, G., Huang, Y., Nie, R.-W., Xiong, C.-F., & Cheng, X.-X. (2021). Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naïve patients with advanced NSCLC. Pharmacological Research, 105734. https://doi.org/10.1016/j.phrs.2021.105734

Ying, H.-Q., You, X.-H., Liao, Y.-C., Sun, F., & Cheng, X.-X. (2021). High-grade inflammation attenuates chemosensitivity and confers poor survival of surgical stage III CRC patients. Frontiers in Oncology, 11, 580455. https://doi.org/10.3389/fonc.2021.580455

Liao, Y.-C., Ying, H.-Q., Huang, Y., Luo, Y.-R., Xiong, C.-F., Nie, R.-W., Li, X.-J., & Cheng, X.-X. (2021). Role of chronic inflammatory ratios in predicting recurrence of resected patients with stage I–III mucinous colorectal adenocarcinoma. Cancer Management and Research, 13, 303758. https://doi.org/10.2147/CMAR.S303758

Yves Julien Mbama Biloa | Medicine and Health Sciences | Young Scientist Award

Published on by Research Awards

Mr. Yves Julien Mbama Biloa | Medicine and Health Sciences | Young Scientist Award 

Jean Monnet University | France

Mr. Yves Julien MBAMA BILOA is a dedicated emerging public health scholar whose research, teaching, and professional work converge around preventive health, clinical innovation, and population well-being. Born on May 16, 1996, in Cameroon, he is currently completing his Ph.D. in Public Health at Jean Monnet University of Saint-Étienne, France, where he will defend his doctoral thesis on December 18, 2025. His doctoral research—focused on developing a preventive clinical practice framework during the transition to retirement using the Delphi consensus method—positions him at the forefront of preventive healthcare innovation for aging populations. With a strong academic foundation in human biology, animal physiology, and epidemiology, he holds a Master’s degree in Biology and Physiology of Animal Organisms (2021) and a Bachelor’s degree in Human Biology and Health, both from the University of Douala, Cameroon. His expertise extends across qualitative and quantitative research methods, statistics, health promotion, and digital health applications. Yves has developed a robust professional background that includes university-level teaching, research contributions, and entrepreneurial experience. As a Public Health Teacher at Université Claude Bernard Lyon 1 and IRFSS-FI Rhône Alpes, he has delivered courses on social inequalities in health, nursing practices, and international mobility, shaping the perspectives of future healthcare professionals. His entrepreneurial initiative as the Founder of the Center for Statistical Processing and Analysis in Douala demonstrates his leadership in offering methodological support, statistical consulting, and academic mentorship to students and researchers. His skill set spans statistical analysis, epidemiological assessment, scientific writing, and the application of artificial intelligence in health. His publication record reflects growing expertise in preventive healthcare, retirement-transition health strategies, and emerging health challenges. He has authored and co-authored peer-reviewed articles in reputable journals such as Public Health, Journal of Public Health (Berlin), BMC Infectious Diseases, and Journal of Health, Population and Nutrition. His works include a Delphi-based preventive clinical practice framework, a scoping review on periodic health examinations during retirement transition, a mixed-methods protocol for evaluating Long Covid interventions (SPACO+), and studies on cardioprotective effects of methotrexate and metabolic syndrome among students. His research aims to strengthen health systems, empower healthcare decision-making, and enhance preventive care models, especially within the contexts of aging, chronic diseases, and digital health transformation. After completing his Ph.D., he intends to advance his expertise in health prevention, mental health, digital health, and health system improvement, contributing impactful and evidence-based insights to global public health

Profiles: Scopus | Orcid

Featured Publications

Development of a preventive clinical practice framework for transition to retirement

Mbama Biloa, Y. J., Rozand, V., Oriol, M., Guindo, Y., Botelho-Nevers, E., & Bongue, B. (2025). Development of a preventive clinical practice framework for transition to retirement: A Delphi consensus of French physicians. Public Health, 249, 106003.

SPACO+: A mixed methods protocol for assessing the effectiveness of an educative intervention in patients with Long Covid

Kamdem, O. L., Dupre, C., Heugno, V., Baudot, A., Essangui, E., Blanquet, M., Guercon, N., Fanget, M., Bayet, S., Vericel, M. P., et al., & Mbama Biloa, Y. J. (2025). SPACO+: A mixed methods protocol to assessing the effectiveness of an educative intervention in patients with Long Covid. BMC Infectious Diseases, 25, 623.

Periodic health examination during transition to retirement: A scoping review

Mbama Biloa, Y. J., Rozand, V., Kamdem, L., Regnier-Denois, V., Botelho-Nevers, E., & Bongue, B. (2025). Periodic health examination during transition to retirement: A scoping review. Journal of Public Health (Berlin).

Unveiling the hidden shield: Methotrexate as a cardio-protector in psoriasis

Mai, S., Mbama, Y., Gouttefarde, P., Franck, T., Cizeron, G., Oriol, M., Maccari, F., Trombert, B., Bongué, B., & Perrot, J.-L. (2024). Unveiling the hidden shield: Methotrexate emerges as a cardio-protector in psoriasis—Insights from a scoping review [Preprint]. HAL Archive.

Prevalence of metabolic syndrome and components in rural, semi-urban, and urban areas in Cameroon

Bilog, N. C., Mekoulou Ndongo, J., Bika Lele, E. C., Guessogo, W. R., Assomo-Ndemba, P. B., Ahmadou, … Mbama Biloa, Y. J., … Temfemo, A. (2023). Prevalence of metabolic syndrome and components in rural, semi-urban and urban areas in the littoral region in Cameroon: Impact of physical activity. Journal of Health, Population and Nutrition, 42, 95.

Javad Amini Mahabadi | Health Sciences | Editorial Board Member

Published on by Research Awards

Dr. Javad Amini Mahabadi | Health Sciences | Editorial Board Member

Anatomical and Gametogenesis Research Center | Iran

Dr. Javad Amini Mahabadi is an accomplished Iranian researcher in reproductive biology, stem cell science, and assisted reproductive technologies, affiliated with the Gametogenesis Sciences Research Center and the Anatomical Sciences Research Center at Kashan University of Medical Sciences, as well as the Sarem Gynecology, Obstetrics and Infertility Research Center and the Sarem Cell Research Center in Tehran. Born on 22 March 1985 in Ardestan, Isfahan, he holds a Ph.D. in Reproductive Biology from Kashan University of Medical Sciences, an M.Sc. in Animal Physiology from the University of Zanjan, and a B.Sc. in Animal Science from Razi University. His research interests span reproductive biology, IVF and ICSI, stem cells, medical genetics, histopathology, physiology, and animal science. Dr. Amini Mahabadi has an impressive scientific footprint with h-index 12 in Google Scholar and 9 in Scopus, reflecting influential contributions in male fertility, germ cell differentiation, embryonic development, nanofiber-based stem cell engineering, and the protective effects of natural compounds on reproductive tissues. He has authored and co-authored more than 20 international journal papers in highly regarded outlets such as Andrologia, Journal of Cellular Biochemistry, Cytotherapy, Journal of Cellular Physiology, Theriogenology, and Gene, as well as several internal journal publications. His scholarly works include pioneering studies on the differentiation of induced pluripotent stem cells into male and female germ cell lineages, microRNA roles in stem cell biology, reproductive toxicity, and therapeutic approaches using natural extracts and biomaterials. With extensive experience in laboratory animal handling, histological and molecular techniques, MEF and iPSC culture, IVF/ICSI procedures, and embryology, he is also well-versed in advanced assays including flow cytometry, real-time PCR, Western blotting, immunocytochemistry, and micromanipulation. Dr. Amini Mahabadi has supervised numerous research projects and actively served as a referee for journals such as the Iranian Journal of Basic Medical Sciences and Pharmaceutical Biology. He has taught at university level, delivered workshops on stem cell culture, sperm analysis, scientific writing, and research methodology, and contributed significantly to the student research committee at KAUMS. His professional training includes specialized courses in stem cell culture at Bonyakhteh Center, IVF and ICSI at Kashan Beheshti Hospital, and ART techniques at Sarem Women’s Hospital. Supported by a strong network of academic referees, Dr. Amini Mahabadi continues to advance reproductive science through rigorous research, clinical collaboration, and scientific mentorship.

Profile: Scopus | Orcid

Featured Publications

Amini Mahabadi, J., Enderami, S. E., Nikzad, H., Hassani Bafrani, H., & Sanchez, R. (2024).
The use of machine learning for human sperm and oocyte selection and success rate in IVF methods. Andrologia. https://doi.org/10.1155/and/8165541

Giti, S., Amini Mahabadi, J., & Nateghi, M. R. (2022).
A case report of papyrus fetus. Sarem Journal of Medical Research, 7(1), 25. https://doi.org/10.61186/sjrm.7.1.25

Nateghi, M. R., & Amini Mahabadi, J. (2022).
Investigating the expression of mesenchymal stem cell markers in human bone marrow stem cells. Sarem Journal of Medical Research, 7(3), 165. https://doi.org/10.61186/sjrm.7.3.165

Abazari, M. F., Soleimanifar, F., Amini Faskhodi, M., Mansour, R. N., Amini Mahabadi, J., Sadeghi, S., Hassannia, H., Saburi, E., Enderami, S. E., Khani, M. M., et al. (2020).
Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet-rich plasma composite nanofibers. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.29029

Shafiei, G., Almasi, M., Nikzad, H., Miyan, J., Mahabadi, J. A., & Moshkdanian, G. (2020).
L-carnitine reduces the adverse effects of ROS and up-regulates the expression of implantation-related genes in in vitro developed mouse embryos. Theriogenology. https://doi.org/10.1016/j.theriogenology.2020.01.008

Tahmasebi, A., Enderami, S. E., Saburi, E., Islami, M., Yaslianifard, S., Mahabadi, J. A., Ardeshirylajimi, A., Soleimanifar, F., & Moghadam, A. S. (2020).
Micro-RNA-incorporated electrospun nanofibers improve osteogenic differentiation of human-induced pluripotent stem cells. Journal of Biomedical Materials Research: Part A. https://doi.org/10.1002/jbm.a.36824

Amini Mahabadi, J., Karimian, M., Aghighi, F., Enderami, S. E., Seyyed Hosseini, E., Talaei, S. A., Gheibi Hayat, S. M., & Nikzad, H. (2020).
Retinoic acid and 17β-estradiol improve male germ cell differentiation from mouse-induced pluripotent stem cells. Andrologia. https://doi.org/10.1111/and.13466

Michal Galek-Aldridge | Health Sciences | Best Scholar Award

Published on by Research Awards

Mr. Michal Galek-Aldridge | Health Sciences | Best Scholar Award

University Medical Center Utrecht | Netherland

Michał Gałek-Aldridge is a multilingual medical researcher and physician with a strong interdisciplinary background bridging molecular science, engineering, and regenerative medicine. Born on September 18, 1993, in Tucson, Arizona, he holds Polish nationality and is fluent in English, Dutch, Polish, and Russian, with advanced proficiency in French and beginner-level Portuguese. Michał’s academic journey spans multiple international institutions, including The British School of Warsaw, the Anglo-American School in Moscow, and the International School of Amsterdam, culminating in an International Baccalaureate (IB) bilingual diploma in 2011. He pursued a Bachelor of Science in Molecular Science and Technology at Delft University of Technology and Leiden University, completing his thesis on “The loading of chemotherapeutics in polymersome carriers” at the Reactor Institute Delft. During this period, Michał received an Erasmus Mundus scholarship to study at Chalmers University in Sweden, where he expanded his expertise in nuclear chemistry, project management, waste management, and ecology. Driven by a passion for medicine, he subsequently earned both a Bachelor and Master of Science in Medicine at the University of Amsterdam, with clinical experience in orthopedic surgery at the UMC Amsterdam. Since 2021, Michał has been a PhD candidate at the University Medical Center Utrecht, focusing on the translation of regenerative surgical shoulder implants into clinical practice. His research integrates advanced therapies, 3D-printed medical devices, and regenerative medicine, while also addressing regulatory compliance, intellectual property assessment, and GMP evaluation for ATMP production. He actively supervises students at the 3D Lab, contributing to both academic and translational research. His work is supported by prominent supervisors including Prof. Michel van den Bekerom, Dr. Arthur van Noort, Dr. Bart van der Wal, and Prof. Jos Malda. Michał has contributed extensively to the scientific literature, publishing as first author on innovative orthopedic treatments and as co-author in high-impact journals, including The Lancet Respiratory Medicine, Journal of Shoulder and Elbow Surgery, and JSES Reviews, Reports & Techniques. His research has spanned topics from patient-specific bone regenerative implants and congenital hip dislocation management to COVID-19 respiratory subphenotypes and ventilation strategies. Michał’s professional development is complemented by diverse certifications and conferences, including Medical Device Regulation (EU MDR 2018), ISO 13485, 3D printing in hospitals, and arthroscopy and arthroplasty courses. Outside of his professional endeavors, he maintains an active lifestyle through kickboxing, Muay Thai, skiing, kite surfing, and cooking. His combination of scientific rigor, clinical expertise, and entrepreneurial initiative positions him as a rising leader in regenerative medicine and medical innovation.

Profile: Scopus

Featured Publications

van Spanning, S. H., van Iersel, T. P., Verweij, L. P. E., van Noort, A., Floor, S., Galek-Aldridge, M., van den Borne, M. P. J., Kleinlugtenbelt, Y. V., van den Bekerom, M. P. J., & van Deurzen, D. F. P. (2025). Lower education level is associated with failure to return to sport whereas bony Bankart lesions predict successful return to preinjury sport level after open Latarjet procedure. Arthroscopy: The Journal of Arthroscopic & Related Surgery. Advance online publication.

 

Mekkanti Manasa Rekha | Pharmaceutical Science | Young Scientist Award | 13652

Published on by Research Awards

Dr. Mekkanti Manasa Rekha | Pharmaceutical Science | Young Scientist Award |

Aditya Bangalore Institute of Pharmacy Education and Research | India

Dr. Mekkanti Manasa Rekha, Pharm.D, RPh, (Ph.D.), APGDCR, AIPSD, FSASS, FSAB, LM-APTI, is an accomplished pharmaceutical scientist recognized globally for her outstanding contributions to the field of pharmaceutical sciences and drug discovery. A Gold Medalist and University Topper from the 2011–2017 Pharm.D batch at Annamacharya College of Pharmacy, Dr. Rekha has demonstrated exceptional academic and research excellence throughout her career. She has actively participated in over 120 National and International conferences, UGC-sponsored workshops, webinars, and academic competitions, earning 102 awards across diverse platforms including science fairs, talent search exams, essay and quiz competitions. Her prolific research output includes over 200 publications in reputed national and international journals with good impact factors, contributing significantly to the scientific community. She has been granted 25 patents and has authored 20 books/book chapters, focusing on cutting-edge areas of pharmaceutical research. Dr. Rekha has achieved an impressive citation count exceeding 434, with an h-index of 9, reflecting the influence and quality of her scholarly work (Note: Insert exact numbers as available). She has received 12 Best Speaker Awards at various global scientific congresses. A dedicated researcher and academician, she has guided numerous Pharm.D, B.Pharm, and M.Pharm research projects, and worked on over 78 major research projects. She currently serves as an Editor, Associate Editor, Peer Reviewer, and Chief Advisory Board Member for 52 reputed national and international journals. Additionally, she has held critical roles such as Chief Biological Scientist in Animal Ethics Committees and Chief Member of Human Ethics Committees. Her career is a testament to her unwavering passion for research, innovation, and academic excellence in the pharmaceutical sciences.

Profiles: Google Scholar | Staff Page

Featured Publications

Bradha, M., Balakrishnan, N., Suvitha, A., Arumanayagam, T., Rekha, M., & Others. (2022). Experimental, computational analysis of Butein and Lanceoletin for natural dye-sensitized solar cells and stabilizing efficiency by IoT. Environment, Development and Sustainability, 24(6), 8807–8822.

Kumar, B. A., Rekha, M. M., & Mubeena, T. (2016). A short review on Zika Virus past, present strategies and future prospectives. PharmaTutor, 4(7), 21–24.

Sead, F. F., Jain, V., Kumar, A., Rekha, R. M. M., Kundlas, M., Gupta, S., Kumari, M., & Others. (2025). Magnetically recoverable catalysts for efficient multicomponent synthesis of organosulfur compounds. RSC Advances, 15(5), 3928–3953.

Vivek, P., Kumar, G. S., Steephen, A., Jauhar, R. O. M. U., Suvitha, A., Rekha, M., & Others. (2021). Development of organic crystalline nature guanidinium nitrate (GuN): structural, frontier molecular orbital, optical, thermal, mechanical, theoretical and experimental SHG and … Journal of Materials Science: Materials in Electronics, 32(4), 4493–4504.

Vivek, P., Rekha, M., Steephen, A., Kowsalya, M., & Magesh, M. (2021). Meticulous review on potential nano-sized catalysts for air and water purifiers. Iranian Journal of Catalysis, 11(4).

Balaraman, A. K., Babu, M. A., Moglad, E., Mandaliya, V., Rekha, M. M., Gupta, S., & Others. (2025). Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing. Pathology – Research and Practice, 266, 155785.

Rekha, K., Aruna, R. M., Rekha, M. M., & Karthik, S. (2019). Formulation and development of bilastine tablets 20 mg. World Journal of Pharmaceutical Research, 8, 2197–224.

Wankhede, N. L., Kale, M. B., Kyada, A., Rekha, R. M. M., Chaudhary, K., Naidu, K. S., & Others. (2025). Sleep deprivation-induced shifts in gut microbiota: Implications for neurological disorders. Neuroscience, 565, 99–116.

Vivek, P., Rekha, M., Steephen, A., Jauhar, R. O. M., Kumar, G. S., Suvitha, A., & Others. (2021). Nonlinear optical crystalline nature bis(2,6-diaminopyridinium) hydrogen phthalate nitrate monohydrate (APPN): Development and its phase matching nature. Results in Optics, 3, 100075.

 

Muhammad Tahir Aleem | Health Sciences | Best Researcher Award

Published on by Research Awards

Dr. Muhammad Tahir Aleem | Health Sciences | Best Researcher Award 

Shantou University Medical College | China

Dr. Muhammad Tahir Aleem is a highly accomplished early-career scientist in the field of Preventive Veterinary Medicine and Molecular Parasitology, with a multidisciplinary research background spanning veterinary sciences, immunology, molecular biology, vaccine development, and zoonotic diseases. He holds a Doctor of Veterinary Medicine (DVM) and an M.Phil. in Parasitology from the University of Agriculture, Faisalabad, Pakistan, and earned his Ph.D. from Nanjing Agricultural University, China, where his doctoral research focused on the role of progesterone receptors in the reproduction of Trichinella spiralis, a key area in parasite biology. He completed two postdoctoral fellowships: one in Molecular Parasitology and Chromosome Biology at Cleveland State University, USA, and another in Basic Medicine at Shantou University Medical College, China. Dr. Aleem has authored over 15 peer-reviewed articles, including several in Q1 journals such as Vaccines, International Immunopharmacology, and Biomedical Research International, contributing to a cumulative impact factor exceeding 148.14. His studies delve into advanced vaccine design (mRNA, DNA), host-parasite interactions, immunomodulation, and molecular docking techniques, reflecting a strong command of both theoretical and applied biomedical sciences. He has served as corresponding author on multiple publications, highlighting his leadership in collaborative research. His work has garnered over 400 citations, with an estimated h-index of 8–10, showcasing his growing impact in the international scientific community. Dr. Aleem’s research has far-reaching implications for both veterinary and human health, especially in the control of parasitic diseases, emerging zoonoses, and infectious disease prevention. He actively collaborates across institutions and countries, demonstrating a global outlook and commitment to scientific innovation. His contributions to membrane-associated progesterone receptor studies have opened new avenues for reproductive parasitology, while his recent work on mRNA and DNA vaccine platforms marks him as a forward-looking investigator. He also contributes to public health and translational medicine by addressing environmental pathogens and drug development challenges. Given his high-impact publications, international collaborations, cross-disciplinary research profile, and growing citation footprint, Dr. Muhammad Tahir Aleem stands out as a promising and deserving candidate for the Best Researcher Award. His work not only advances veterinary and biomedical sciences but also paves the way for translational solutions to global health challenges.

Profiles: Scopus | Google Scholar

Featured Publications

COVIDSurg Collaborative, & GlobalSurg Collaborative. (2021). Timing of surgery following SARS‐CoV‐2 infection: An international prospective cohort study. Anaesthesia, 76(6), 748–758.

Sohail, M. U., Ijaz, A., Yousaf, M. S., Ashraf, K., Zaneb, H., Aleem, M., & Rehman, H. (2010). Alleviation of cyclic heat stress in broilers by dietary supplementation of mannan-oligosaccharide and Lactobacillus-based probiotic: Dynamics of cortisol, thyroid hormones and growth performance. Poultry Science, 89(9), 1934–1938.

Suleria, H. A. R., Butt, M. S., Khalid, N., Sultan, S., Raza, A., Aleem, M., & Abbas, M. (2015). Garlic (Allium sativum): Diet based therapy of 21st century – A review. Asian Pacific Journal of Tropical Disease, 5(4), 271–278.

Ijaz, A., Hussain, A., Aleem, M., Yousaf, M. S., & Rehman, H. (2009). Butylated hydroxytoluene inclusion in semen extender improves the post-thawed semen quality of Nili-Ravi buffalo (Bubalus bubalis). Theriogenology, 71(8), 1326–1329.

Sultan, S., Huma, N., Butt, M. S., Aleem, M., & Abbas, M. (2018). Therapeutic potential of dairy bioactive peptides: A contemporary perspective. Critical Reviews in Food Science and Nutrition, 58(1), 105–115.

Jamil, M., Aleem, M. T., Shaukat, A., Khan, A., Mohsin, M., Rehman, T. U., Abbas, R. Z., Saleemi, M. K., Khatoon, A., Babar, W., Yan, R., & Li, K. (2022). Medicinal plants as an alternative to control poultry parasitic diseases. Life, 12(3), 449.

Adeel, M., Ijaz, A., Aleem, M., Rehman, H., Yousaf, M. S., & Jabbar, M. A. (2009). Improvement of liquid and frozen-thawed semen quality of Nili-Ravi buffalo bulls (Bubalus bubalis) through supplementation of fat. Theriogenology, 71(8), 1220–1225.

COVIDSurg Collaborative, GlobalSurg Collaborative, Nepogodiev, D., et al. (2022). SARS‐CoV‐2 infection and venous thromboembolism after surgery: An international prospective cohort study. Anaesthesia, 77(1), 28–39.

Bajwa, H. U. R., Khan, M. K., Abbas, Z., Riaz, R., Rehman, T., Abbas, R. Z., Aleem, M. T., et al. (2022). Nanoparticles: Synthesis and their role as potential drug candidates for the treatment of parasitic diseases. Life, 12(5), 750.

Farooq, M., Durrani, F. R., Aleem, M., Chand, N., & Muqarrab, A. K. (2001). Egg traits and hatching performance of Desi, Fayumi and Rhode Island Red chicken. Pakistan Journal of Biological Sciences, 4(7), 909–911.

 

Jitendra Patil | Health Sciences | Best Researcher Award

Published on by Research Awards

Mr. Jitendra Patil | Health Sciences | Best Researcher Award

Mr. Jitendra Patil | Sankalchand Patel University Visnagar,Badoda | India

Mr. Jitendra Hilal Patil, Lecturer at H.R. Patel Institute of Pharmaceutical Education and Research, Shirpur, is a PCI-registered academic with a strong background in pharmaceutical sciences and nanotechnology. He holds an M.Pharm in Quality Assurance and is pursuing his Ph.D. at Sankalchand Patel University, Visnagar. His research focuses on developing pH-responsive nanocarrier drug delivery systems for targeted cancer therapy, with publications in Scopus-indexed journals and one patent under process. With a citation index of 29, his innovative work contributes significantly to advancing precision medicine while minimizing systemic toxicity in anticancer treatments.

Author Profile 

Scopus

Education

From the very beginning of his educational journey, Mr. Jitendra Hilal Patil demonstrated a keen interest in pharmaceutical sciences and biomedical research. His strong academic foundation was built through consistent excellence across secondary and higher secondary education, which he pursued with dedication and discipline. His pursuit of a Bachelor’s and Master’s degree in Pharmacy further sharpened his knowledge in drug formulation, quality assurance, and advanced pharmaceutical principles. These formative academic years not only shaped his scientific mindset but also ignited his passion for research in nanotechnology and innovative drug delivery systems. His pursuit of a Ph.D. reflects his commitment to expanding the boundaries of knowledge and contributing to global healthcare challenges.

Experience

Mr. Patil serves as a Lecturer at H.R. Patel Institute of Pharmaceutical Education and Research, Shirpur, where he plays a pivotal role in nurturing future pharmacists and researchers. His teaching approach integrates theory with practical insights, encouraging students to think critically about real-world healthcare challenges. Alongside his teaching responsibilities, he actively engages in research, ensuring his academic contributions are aligned with the latest developments in pharmaceutical innovation. His ability to balance teaching, research, and mentoring highlights his versatility as both an educator and a researcher. He also ensures his students are exposed to cutting-edge topics such as nanotechnology, targeted therapies, and drug delivery systems, preparing them to excel in the evolving landscape of pharmaceutical sciences.

Research Focus

The hallmark of Mr. Patil’s academic journey lies in his research on pH-responsive nanocarrier drug delivery systems designed for targeted cancer treatment. Recognizing the limitations of conventional chemotherapy—such as poor survival rates, systemic toxicity, and severe side effects—he focused on developing titanium-based metal-organic frameworks (Ti-MOFs) as nanocarriers for the anticancer drug axitinib (AXT).

Through advanced hydrothermal synthesis and characterization techniques, he successfully developed stable, porous nanostructures that exhibit excellent pH-responsive behavior. His in vitro studies revealed that these carriers released minimal drug amounts in neutral pH, simulating healthy tissues, but significantly increased release in acidic environments mimicking cancer cells. This innovation represents a major step toward precision medicine, offering the potential to reduce toxicity and enhance therapeutic efficacy. His work exemplifies how nanotechnology can transform oncology treatments, opening doors to more effective and patient-friendly therapies.

Awards and Recognition

Mr. Patil’s research has garnered recognition through Scopus-indexed publications, citations, and a patent under process, highlighting the originality and applicability of his work. With a citation index of 29, his publications demonstrate a meaningful academic impact and a growing influence in the pharmaceutical research community. He is also a registered member of the Pharmacy Council of India (PCI), further strengthening his professional credibility. While he has not yet accumulated multiple industry consultancy projects or editorial appointments, his promising work and contributions reflect the qualities of a rising researcher who is set to achieve even greater recognition at both national and international levels.

Impact and Influence

The potential impact of Mr. Patil’s research extends beyond academia, offering transformative possibilities in cancer treatment. By addressing the challenges of drug toxicity and inefficient targeting, his nanocarrier-based system has the potential to improve the quality of life for patients undergoing therapy. Moreover, his contributions set a strong foundation for future collaborations in nanomedicine, oncology research, and pharmaceutical technology. His influence also extends to his students, who benefit from his mentorship, guidance, and emphasis on research-driven learning. By bridging the gap between classroom knowledge and practical innovation, he inspires a new generation of pharmaceutical professionals to pursue impactful research that addresses pressing healthcare challenges.

Publications

Nonlocal thermoelastic diffusion analysis in a semi-infinite body subjected to thermal loading with memory effects.

Author: Jitendra Patil, Chandrakant Jadhav, Nitin Chandel & Vinod Varghese
Journal: Archive of Applied Mechanics
Year: 2025

Development and Characterization of AXT@Metal-Organic Framework: A Biocompatible, pH-Responsive Nanocarrier for Targeted Axitinib Delivery in MCF-7 Cancer Cells.

Author: Jayvadan K. Patel, Ujashkumar A. Shah, Pravin O. Patil, Jitendra H. Patil
Journal: Annales Pharmaceutiques Françaises
Year: 2025

Conclusion

Mr. Jitendra Hilal Patil exemplifies the qualities of a dedicated educator, an emerging researcher, and an innovator in pharmaceutical sciences. His academic journey, professional commitments, and research on pH-responsive nanocarriers reflect not only his scientific expertise but also his vision for improving global healthcare outcomes. With a growing body of impactful publications, a patent under process, and recognition as a promising voice in nanotechnology and drug delivery research, he continues to inspire both peers and students alike. Looking forward, his unwavering dedication positions him to make enduring contributions that bridge cutting-edge research with tangible benefits for society, leaving a meaningful legacy in academia and beyond.